S. Bedja obtained her bachelor’s degree in Cellular biology and Physiology at the University of Reims Champagne-Ardenne, France in 2017. Then, she moved to Paris to start a master’s degree in Biology and Experimental therapies at the University of Paris 13, France, which she obtained in July 2019. After that, she moved to Montpellier to work with Morris’s team on kinase dysregulation and CDK4 inhibitors in cancer.
During her master’s degree, she did two internships in U1152 ”Physiopathology and epidemiology in lung diseases” in Pretolani’s team under supervision of Dr Séverine Létuvé. She developed strong skills in cellular biology, molecular biology, histology and culture cell because she had the opportunity to work with human bronchial epithelial cells, obtained by extraction from pulmonary biopsies and bronchia.
In 2019, she presented a communication on her work at the Lungstorming meeting, organized by GSK in Nans-les-Pains.